Date | Product | Disease | Phase | Company | Therapeutic area |
---|---|---|---|---|---|
2013-04-16 | Amikacin Inhale (NKTR-061 - BAY41-6551) | Gram-negative pneumonia |
3 | Bayer Healthcare (Germany) Nektar Therapeutics (USA) | Infectious diseases |
2013-04-11 | StemEx® (carlecortemcel-l) | blood cancers such as leukemia and lymphoma, who cannot find a family related, matched bone marrow donor. |
2-3 | Gamida Cell (Israel) Teva Pharmaceutical Industries (Israel) | Cancer - Oncology |
2013-04-11 | C3BS-CQR-1 (C-Cure®) | heart failure | 2 | Celyad previously known as Cardio3 Biosciences (Belgium) | Cardiovascular diseases |
2013-04-11 | IPH33 | preclinical studies | Innate Pharma (France) | Inflammatory diseases | |
2013-04-11 | IPH41 | Sezary syndrome, lymphoma |
preclinical studies | Innate Pharma (France) | Cancer - Oncology - Rare diseases |
2013-04-10 | AV0113 (IL-12-secreting dendritic cells loaded with autologous tumour lysate) | glioma | 2 | Activartis Biotech (Austria) | Cancer - Oncology |
2013-04-08 | Selincro® | alcohol dependence | 3 | Lundbeck (Denmark) | CNS diseases |
2013-04-04 | BI-505 | multiple myeloma | 1 | BioInvent (Sweden) | Cancer - Oncology |
2013-04-04 | SRM003 - Vascugel | Arteriovenous Fistula (AVF) maturation and AV Graft (AVG) patency to facilitate hemodialysis in patients with End Stage Renal Disease (ESRD) |
2 | Shire (UK) | Renal diseases - Kidney diseases |
2013-04-03 | Benlysta® (belimumab) | ANCA (Anti-neutrophil Cytoplasmic Antibodies) positive vasculitis | 3 | GSK (UK) | Inflammatory diseases |
2013-04-03 | somatoprim (DG3173 - somatostatin analogue) | acromegaly | 2a | Aspireo Pharmaceuticals (Israel) | Rare diseases - Hormonal diseases - Endocrine diseases |
2013-04-01 | elacytarabine | late-stage acute myeloid leukaemia | 3 | Clavis Pharma (Norway) | Cancer - Oncology |
2013-04-01 | Neo-Kidney Augment™ | chronic kidney disease (CKD) |
1 | Tengion (USA) | Renal diseases - Kidney diseases |
2013-03-27 | vaccines against dengue and chikungunya fever | dengue fever |
preclinical studies | Themis Bioscience (Austria) | Infectious diseases |
2013-03-27 | GLPG0974 | inflammatory bowel disease | 1 | Galapagos (Belgium) | Inflammatory diseases |
2013-03-26 | ReN009 stem cell therapy | critical limb ischaemia | 1 | Reneuron (UK) | Cardiovascular diseases |
2013-03-25 | ARGX-112 | preclinical | Argen-X (The Netherlands-Belgium) | Dermatological diseases | |
2013-03-21 | ODM-101 | Parkinson's disease | 2 | Orion Corporation (Finland) | Neurodegenerative diseases - CNS diseases |
2013-03-21 | ORM-12741 | Alzheimer's disease | 2a | Orion Corporation (Finland) | Neurodegenerative diseases |
2013-03-20 | PAP-1 | psoriasis |
1b | Circassia (UK) | Autoimmune diseases – Dermatological diseases |